Mapping of the ligand binding domain of the human tachykinin NK2 receptor

被引：0
|
作者：
Findlay, JBC [1 ]
机构：
[1] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1999年 / 128卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
308P
引用
收藏
页码：U49 / U49
页数：1
相关论文
共 50 条
  • [21] Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome
    Lecci, A
    Capriati, A
    Maggi, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (08) : 1249 - 1263
  • [22] COMPETITIVE ANTAGONISTS DISCRIMINATE BETWEEN NK2 TACHYKININ RECEPTOR SUBTYPES
    MAGGI, CA
    PATACCHINI, R
    GIULIANI, S
    ROVERO, P
    DION, S
    REGOLI, D
    GIACHETTI, A
    MELI, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (03) : 588 - 592
  • [23] α,α-cyclopentaneglycine dipeptides capped with biaryls as tachykinin NK2 receptor antagonists
    Porcelloni, Marina
    D'Andrea, Piero
    Rossi, Cristina
    Sisto, Alessandro
    Ettorre, Alessandro
    Madami, Andrea
    Altamura, Maria
    Giuliani, Sandro
    Meini, Stefania
    Fattori, Daniela
    CHEMMEDCHEM, 2008, 3 (07) : 1048 - 1060
  • [24] Pharmacological evaluation of α and β human tachykinin NK2 receptor splice variants expressed in CHO cells
    Bellucci, F
    Meini, S
    Catalioto, RM
    Catalani, C
    Giuliani, S
    Quartara, L
    Giolitti, A
    Faiella, A
    Rotondaro, L
    Candenas, ML
    Pinto, FM
    Maggi, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 499 (03) : 229 - 238
  • [25] Identification of a tachykinin NK2 receptor splice variant and its expression in human and rat tissues
    Candenas, ML
    Cintado, CG
    Pennefather, JN
    Pereda, MT
    Loizaga, JM
    Maggi, CA
    Pinto, FM
    LIFE SCIENCES, 2002, 72 (03) : 269 - 277
  • [26] THE NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST SR-48968 INTERACTS WITH HUMAN, BUT NOT RAT, CLONED TACHYKININ NK3 RECEPTORS
    CHUNG, FZ
    WU, LH
    VARTANIAN, MA
    WATLING, KJ
    GUARD, S
    WOODRUFF, GN
    OXENDER, DL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (03) : 967 - 972
  • [27] Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK2 receptor
    Renzetti, AR
    Catalioto, RM
    Criscuoli, M
    Cucchi, P
    Ferrer, C
    Giolitti, A
    Guelfi, M
    Rotondaro, L
    Warner, FJ
    Maggi, CA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 290 (02): : 487 - 495
  • [28] CHARACTERIZATION OF TACHYKININ NK2 RECEPTORS IN HUMAN URINARY-BLADDER
    ZENG, XP
    MOORE, KH
    BURCHER, E
    JOURNAL OF UROLOGY, 1995, 153 (05): : 1688 - 1692
  • [29] Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis
    Montuschi, P
    Curro, D
    Ciabattoni, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (1-2) : R1 - R3
  • [30] NEW SPIROPIPERIDINES AS POTENT AND SELECTIVE NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONISTS
    SMITH, PW
    COOPER, AWJ
    BELL, R
    BERESFORD, IJM
    GORE, PM
    MCELROY, AB
    PRITCHARD, JM
    SAEZ, V
    TAYLOR, NR
    SHELDRICK, RLG
    WARD, P
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (19) : 3772 - 3779
12345